The New England journal of medicine

publication venue for

Case 26-2023: A 15-Year-Old Girl with Abdominal Pain and an Ovarian Mass. 2023
Case 38-2022: A 21-Year-Old Woman with Fatigue and Weight Gain. 2022
Diagnosis of Achilles' Tendon Rupture during a Virtual Examination. 2021
Images in clinical medicine. Whooping cough in an adult. 2012
Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. 2010
Clinical decisions. Management of stable coronary disease. 2007
Clinical problem-solving. Needle in a haystack. 2006
Perinatal transmission of the agent of human granulocytic ehrlichiosis. 1998
Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. 1997
Brief report: cerebral syphilitic gumma confirmed by the polymerase chain reaction in a man with human immunodeficiency virus infection. 1994
Reversible cardiac dysfunction (hibernation) from ischemia due to compression of the coronary arteries by a pseudoaneurysm. 1991
Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. 1977
Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma.. 391. 2024
Tirzepatide for Obesity Treatment and Diabetes Prevention. 2024
Covering Long-Term Care at Home? Implications of a New Proposal for Expanding Medicare. 2024
Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis. 2024
Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.. 391. 2024
Safety of Kidney Transplantation from Donors with HIV.. 391. 2024
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. 2024
Cognitive Motor Dissociation in Disorders of Consciousness.. 391. 2024
Collective Trauma and Commemoration - A Moment of Silence, Please.. 391. 2024
Exagamglogene Autotemcel for Transfusion-Dependent β-Thalassemia. 2024
Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction. 2024
Vertical Integration and the Transformation of American Medicine. 2024
Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.. 390. 2024
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera.. 390. 2024
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.. 390. 2024
Drug-Eluting Resorbable Scaffold versus Angioplasty for Infrapopliteal Artery Disease. 2023
Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper.. 389. 2023
Inhaled Fluticasone Furoate for Outpatient Treatment of Covid-19.. 389. 2023
Threatening the Global AIDS Response - Obstacles to PEPFAR's Reauthorization. 2023
Preoperative Treatment of Locally Advanced Rectal Cancer.. 389. 2023
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.. 389. 2023
A Dual-Chamber Leadless Pacemaker. 2023
Addressing Serious Illness Care in Medicare Advantage.. 388. 2023
Trial of Globus Pallidus Focused Ultrasound Ablation in Parkinson's Disease.. 388. 2023
Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer.. 388. 2023
When Weight Impacts Health.. 388. 2023
Weight and Health - Pathophysiology and Therapies.. 387. 2022
Click Here for Better Chemistry.. 387. 2022
Covid-19 Vaccine Protection among Children and Adolescents in Qatar. 2022
GPRC5D-Targeted CAR T Cells for Myeloma.. 387. 2022
Bronchodilators in Tobacco-Exposed Persons with Symptoms and Preserved Lung Function.. 387. 2022
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.. 386. 2022
Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections. 2022
PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer.. 386. 2022
Tirzepatide Once Weekly for the Treatment of Obesity.. 387. 2022
Treatment for Mild Chronic Hypertension during Pregnancy. 2022
Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar. 2022
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.. 386. 2022
Darolutamide and Survival in Metastatic, Hormone-Sensitive Prostate Cancer.. 386. 2022
Fractional Flow Reserve-Guided PCI as Compared with Coronary Bypass Surgery.. 386. 2021
The Billboard. 2021
Spinal Anesthesia or General Anesthesia for Hip Surgery in Older Adults. 2021
Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. 2021
A Human Pleiotropic Multiorgan Condition Caused by Deficient Wnt Secretion.. 385. 2021
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. 2021
Race, Genetic Ancestry, and Estimating Kidney Function in CKD.. 385. 2021
Prospective, Multicenter, Controlled Trial of Mobile Stroke Units.. 385. 2021
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.. 385. 2021
Variant PNLDC1, Defective piRNA Processing, and Azoospermia.. 385. 2021
Acquired Resistance to KRAS^G12C Inhibition in Cancer.. 384. 2021
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer. 2021
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.. 384. 2021
A Hidden Opportunity - Medicaid's Role in Supporting Equitable Access to Clinical Trials.. 384. 2021
Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease.. 384. 2021
Detained.. 384. 2021
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.. 384. 2021
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.. 384. 2021
Oncolytic HSV-1 G207 Immunovirotherapy for Pediatric High-Grade Gliomas.. 384. 2021
A Population-Based Study of Genes Previously Implicated in Breast Cancer.. 384. 2021
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.. 383. 2020
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.. 384. 2020
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19.. 383. 2020
A Randomized Trial Comparing Antibiotics with Appendectomy for Appendicitis.. 383. 2020
Atezolizumab for First-Line Treatment of PD-L1-Selected Patients with NSCLC.. 383. 2020
KRAS^G12C Inhibition with Sotorasib in Advanced Solid Tumors.. 383. 2020
Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment.. 383. 2020
Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.. 383. 2020
Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer.. 383. 2020
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.. 383. 2020
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.. 383. 2020
Reconsidering the Trade-offs of Prostate Cancer Screening.. 382. 2020
Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer.. 382. 2020
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.. 383. 2020
Stigma Reduction to Combat the Addiction Crisis - Developing an Evidence Base.. 382. 2020
Initial Invasive or Conservative Strategy for Stable Coronary Disease.. 382. 2020
Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation.. 382. 2020
Understanding the Rewards of Successful Drug Development - Thinking Inside the Box.. 382. 2020
Which Drug Prices Should Medicare Negotiate? A "Too Little" or "Too Late" Approach.. 381. 2019
Metoprolol for the Prevention of Acute Exacerbations of COPD.. 381. 2019
Isoniazid Preventive Therapy in HIV-Infected Pregnant and Postpartum Women.. 381. 2019
Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.. 381. 2019
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.. 381. 2019
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency.. 381. 2019
Ticagrelor in Patients with Stable Coronary Disease and Diabetes.. 381. 2019
Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.. 381. 2019
Vitamin D Supplementation and Prevention of Type 2 Diabetes.. 381. 2019
Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection.. 380. 2019
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.. 380. 2019
Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer.. 380. 2019
Bilateral versus Single Internal-Thoracic-Artery Grafts at 10 Years.. 380. 2019
Diagnostic Utility of Exome Sequencing for Kidney Disease.. 380. 2018
Sorafenib for Advanced and Refractory Desmoid Tumors.. 379. 2018
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome.. 379. 2018
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease.. 379. 2018
Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer.. 379. 2018
Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis.. 379. 2018
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.. 379. 2018
Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain.. 379. 2018
National Coverage Analysis of CAR-T Therapies - Policy, Evidence, and Payment.. 379. 2018
Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma.. 379. 2018
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer.. 378. 2018
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.. 379. 2018
Durable Remissions with Ivosidenib in IDH1-Mutated Relapsed or Refractory AML.. 378. 2018
Radial-Artery or Saphenous-Vein Grafts in Coronary-Artery Bypass Surgery.. 378. 2018
Study of Intraventricular Cerliponase Alfa for CLN2 Disease.. 378. 2018
Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD.. 378. 2018
Time Out - Charting a Path for Improving Performance Measurement.. 378. 2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.. 378. 2018
Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma.. 378. 2018
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.. 378. 2018
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.. 378. 2018
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.. 378. 2018
Efficacy of Larotrectinib in TRK Fusion-Positive Cancers in Adults and Children.. 378. 2018
Placing a Lumbar Epidural Catheter.. 378. 2018
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia.. 378. 2018
Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.. 377. 2017
Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.. 377. 2017
Airway Mucin Concentration as a Marker of Chronic Bronchitis.. 377. 2017
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.. 377. 2017
Trial of Tocilizumab in Giant-Cell Arteritis.. 377. 2017
Sharing Clinical and Genomic Data on Cancer - The Need for Global Solutions.. 376. 2017
Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis.. 376. 2017
Delays in Emergency Care and Mortality during Major U.S. Marathons.. 376. 2017
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.. 376. 2017
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients.. 376. 2017
Assessing the Risks Associated with MRI in Patients with a Pacemaker or Defibrillator.. 376. 2017
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.. 376. 2017
Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.. 376. 2017
Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.. 376. 2017
Thromboprophylaxis after Knee Arthroscopy.. 376. 2017
Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults.. 376. 2016
A Fully Magnetically Levitated Circulatory Pump for Advanced Heart Failure.. 376. 2016
Randomized Trial of Bilateral versus Single Internal-Thoracic-Artery Grafts.. 375. 2016
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation.. 375. 2016
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy.. 375. 2016
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy.. 375. 2016
Adalimumab in Patients with Active Noninfectious Uveitis.. 375. 2016
Sharing Data from Cardiovascular Clinical Trials--A Proposal.. 375. 2016
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer.. 375. 2016
Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.. 374. 2016
Extended Thromboprophylaxis with Betrixaban in Acutely Ill Medical Patients.. 375. 2016
Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function.. 374. 2016
Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders.. 374. 2016
Survival Benefit with Kidney Transplants from HLA-Incompatible Live Donors.. 374. 2016
Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura.. 374. 2016
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.. 374. 2015
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis.. 373. 2015
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.. 373. 2015
New Math on Drug Cost-Effectiveness.. 373. 2015
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.. 374. 2015
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.. 373. 2015
Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.. 373. 2015
Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma.. 373. 2015
Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.. 373. 2015
Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.. 373. 2015
Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.. 373. 2015
Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor.. 373. 2015
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.. 373. 2015
Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation.. 373. 2015
Behavioral economics and physician compensation--promise and challenges.. 372. 2015
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.. 372. 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer.. 373. 2015
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.. 373. 2015
Gene-panel sequencing and the prediction of breast-cancer risk.. 372. 2015
Symbol of health system transformation? Assessing the CMS Innovation Center.. 372. 2015
Intensive diabetes therapy and ocular surgery in type 1 diabetes.. 372. 2015
Nivolumab and ipilimumab versus ipilimumab in untreated melanoma.. 372. 2015
Effects of red-cell storage duration on patients undergoing cardiac surgery.. 372. 2015
Ibrutinib in previously treated Waldenström's macroglobulinemia.. 372. 2015
Valganciclovir for symptomatic congenital cytomegalovirus disease.. 372. 2015
On marginal health care--probability inflation and the tragedy of the commons.. 372. 2015
A new initiative on precision medicine.. 372. 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancer.. 372. 2015
Carfilzomib, lenalidomide, and dexamethasone for relapsed multiple myeloma.. 372. 2014
PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma.. 372. 2014
Long-term safety and efficacy of factor IX gene therapy in hemophilia B.. 371. 2014
Genetic basis for clinical response to CTLA-4 blockade in melanoma.. 371. 2014
Atenolol versus losartan in children and young adults with Marfan's syndrome.. 371. 2014
An interferon-free antiviral regimen for HCV after liver transplantation.. 371. 2014
Antidepressants' black-box warning--10 years later.. 371. 2014
Antibiotic resistance--problems, progress, and prospects.. 371. 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancer.. 371. 2014
Transplantation outcomes for severe combined immunodeficiency, 2000-2009.. 371. 2014
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer.. 371. 2014
Enzalutamide in metastatic prostate cancer before chemotherapy.. 371. 2014
Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.. 371. 2014
Embracing oral cholera vaccine--shifting response to cholera.. 370. 2014
Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib.. 370. 2014
Pasireotide for postoperative pancreatic fistula.. 370. 2014
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis.. 370. 2014
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.. 370. 2014
The economics of graduate medical education.. 370. 2014
Comparative effectiveness questions in oncology.. 370. 2014
Bariatric surgery versus intensive medical therapy for diabetes--3-year outcomes.. 370. 2014
Darapladib for preventing ischemic events in stable coronary heart disease.. 370. 2014
Transcatheter aortic-valve replacement with a self-expanding prosthesis.. 370. 2014
Ceritinib in ALK-rearranged non-small-cell lung cancer.. 370. 2014
Improved survival with bevacizumab in advanced cervical cancer.. 370. 2014
Early-onset stroke and vasculopathy associated with mutations in ADA2.. 370. 2014
Risk of a thrombotic event after the 6-week postpartum period.. 370. 2014
Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.. 370. 2014
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.. 370. 2014
Stenting and medical therapy for atherosclerotic renal-artery stenosis.. 370. 2013
Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine.. 369. 2013
Professionalism and caring for Medicaid patients--the 5% commitment?. 369. 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantation.. 369. 2013
Pazopanib versus sunitinib in metastatic renal-cell carcinoma.. 369. 2013
Efficacy of remission-induction regimens for ANCA-associated vasculitis.. 369. 2013
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.. 369. 2013
Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.. 369. 2013
A rude awakening--the perioperative sleep apnea epidemic.. 368. 2013
Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia.. 369. 2013
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma.. 369. 2013
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.. 368. 2013
Nivolumab plus ipilimumab in advanced melanoma.. 369. 2013
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.. 369. 2013
Crizotinib versus chemotherapy in advanced ALK-positive lung cancer.. 368. 2013
Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma.. 368. 2013
Surgery versus physical therapy for a meniscal tear and osteoarthritis.. 368. 2013
Effect of platelet inhibition with cangrelor during PCI on ischemic events.. 368. 2013
Updating the HIV-testing guidelines--a modest change with major consequences.. 368. 2013
Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer.. 368. 2013
Effect of daily chlorhexidine bathing on hospital-acquired infection.. 368. 2013
After Newtown--public opinion on gun policy and mental illness.. 368. 2013
Peginesatide for anemia in patients with chronic kidney disease not receiving dialysis.. 368. 2013
Fever of unknown origin or fever of too many origins?. 368. 2013
Appropriateness criteria and elective procedures--total joint arthroplasty.. 367. 2012
Abiraterone in metastatic prostate cancer without previous chemotherapy.. 368. 2012
Ponatinib in refractory Philadelphia chromosome-positive leukemias.. 367. 2012
Tolvaptan in patients with autosomal dominant polycystic kidney disease.. 367. 2012
Pulmonary arterial enlargement and acute exacerbations of COPD.. 367. 2012
HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.. 367. 2012
Increased survival with enzalutamide in prostate cancer after chemotherapy.. 367. 2012
Coronary CT angiography versus standard evaluation in acute chest pain.. 367. 2012
Cumulative birth rates with linked assisted reproductive technology cycles.. 366. 2012
Delays and difficulties in assessing metal-on-metal hip implants.. 367. 2012
Hereditary systemic amyloidosis due to Asp76Asn variant β2-microglobulin.. 366. 2012
Efficacy and safety of vismodegib in advanced basal-cell carcinoma.. 366. 2012
Drotrecogin alfa (activated) in adults with septic shock.. 366. 2012
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.. 366. 2012
Lenalidomide after stem-cell transplantation for multiple myeloma.. 366. 2012
Metabolic health and nuclear-receptor sensitivity.. 366. 2012
Brodalumab, an anti-interleukin-17-receptor antibody for psoriasis.. 366. 2012
Bariatric surgery versus intensive medical therapy in obese patients with diabetes.. 366. 2012
Closure or medical therapy for cryptogenic stroke with patent foramen ovale.. 366. 2012
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia.. 366. 2012
A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.. 366. 2012
Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib.. 366. 2012
RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors.. 366. 2012
Thrombin-receptor antagonist vorapaxar in acute coronary syndromes.. 366. 2011
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.. 365. 2011
Stenting versus aggressive medical therapy for intracranial arterial stenosis.. 365. 2011
Azithromycin for prevention of exacerbations of COPD.. 365. 2011
Apixaban with antiplatelet therapy after acute coronary syndrome.. 365. 2011
Clinical effect of point mutations in myelodysplastic syndromes.. 364. 2011
Improved survival with vemurafenib in melanoma with BRAF V600E mutation.. 364. 2011
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.. 364. 2011
Abiraterone and increased survival in metastatic prostate cancer.. 364. 2011
Resistance to BRAF inhibition in melanomas.. 364. 2011
Rosiglitazone, PPARγ, and type 2 diabetes.. 363. 2010
Mutations in GNA11 in uveal melanoma.. 363. 2010
Safety of anacetrapib in patients with or at high risk for coronary heart disease.. 363. 2010
Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas.. 363. 2010
Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.. 363. 2010
Creating accountable care organizations.. 363. 2010
Intensive blood-pressure control in hypertensive chronic kidney disease.. 363. 2010
Inhibition of mutated, activated BRAF in metastatic melanoma.. 363. 2010
Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.. 363. 2010
Rituximab versus cyclophosphamide for ANCA-associated vasculitis.. 363. 2010
Improved survival with ipilimumab in patients with metastatic melanoma.. 363. 2010
Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease.. 362. 2010
L-histidine decarboxylase and Tourette's syndrome.. 362. 2010
Specialist physician practices as patient-centered medical homes.. 362. 2010
Robot-assisted therapy for long-term upper-limb impairment after stroke.. 362. 2010
A randomized study of alglucosidase alfa in late-onset Pompe's disease.. 362. 2010
A map to bad policy--hospital efficiency measures in the Dartmouth Atlas.. 362. 2010
Dose of prophylactic platelet transfusions and prevention of hemorrhage.. 362. 2010
The GHESKIO field hospital and clinics after the earthquake in Haiti--dispatch 3 from Port-au-Prince.. 362. 2010
The GHESKIO refugee camp after the earthquake in Haiti--dispatch 2 from Port-au-Prince.. 362. 2010
Single-dose liposomal amphotericin B for visceral leishmaniasis in India.. 362. 2010
The earthquake in Haiti--dispatch from Port-au-Prince.. 362. 2010
Lack of cyclophilin B in osteogenesis imperfecta with normal collagen folding.. 362. 2010
Health care reform and the need for comparative-effectiveness research.. 362. 2010
Variants of DENND1B associated with asthma in children.. 362. 2009
Intravenous platelet blockade with cangrelor during PCI.. 361. 2009
Platelet inhibition with cangrelor in patients undergoing PCI.. 361. 2009
The hedgehog pathway and pancreatic cancer.. 361. 2009
The clinical course of advanced dementia.. 361. 2009
Injectable collagenase clostridium histolyticum for Dupuytren's contracture.. 361. 2009
Inhibition of the hedgehog pathway in advanced basal-cell carcinoma.. 361. 2009
Ticagrelor versus clopidogrel in patients with acute coronary syndromes.. 361. 2009
Premature release of data from clinical trials of ezetimibe.. 361. 2009
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery.. 361. 2009
Who has capacity?. 361. 2009
Forever unprepared--the predictable unpredictability of pathogens.. 361. 2009
A randomized trial of therapies for type 2 diabetes and coronary artery disease.. 360. 2009
Adjuvant chemotherapy in older women with early-stage breast cancer.. 360. 2009
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.. 360. 2009
Early versus delayed, provisional eptifibatide in acute coronary syndromes.. 360. 2009
A randomized trial of rosuvastatin in the prevention of venous thromboembolism.. 360. 2009
Ethical and scientific implications of the globalization of clinical research.. 360. 2009
Limits on Medicare's ability to control rising spending on cancer drugs.. 360. 2009
Dicer, Drosha, and outcomes in patients with ovarian cancer.. 359. 2008
Clinical decisions. Management of prostate cancer.. 359. 2008
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein.. 359. 2008
Maraviroc for previously treated patients with R5 HIV-1 infection.. 359. 2008
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis.. 359. 2008
Electronic health records in ambulatory care--a national survey of physicians.. 359. 2008
Effects of intensive glucose lowering in type 2 diabetes.. 358. 2008
Bivalirudin during primary PCI in acute myocardial infarction.. 358. 2008
Class-sparing regimens for initial treatment of HIV-1 infection.. 358. 2008
Surgical versus nonsurgical therapy for lumbar spinal stenosis.. 358. 2008
HLA-mismatched renal transplantation without maintenance immunosuppression.. 358. 2008
Respiratory effects of exposure to diesel traffic in persons with asthma.. 357. 2007
Eltrombopag for the treatment of chronic idiopathic thrombocytopenic purpura.. 357. 2007
Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America.. 357. 2007
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.. 357. 2007
HER2 and response to paclitaxel in node-positive breast cancer.. 357. 2007
HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.. 357. 2007
Use of a continuous-flow device in patients awaiting heart transplantation.. 357. 2007
Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.. 357. 2007
Whole-genome analysis of sporadic amyotrophic lateral sclerosis.. 357. 2007
Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis.. 356. 2007
Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.. 356. 2007
Expanding the black box - depression, antidepressants, and the risk of suicide.. 356. 2007
Care patterns in Medicare and their implications for pay for performance.. 356. 2007
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.. 356. 2007
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.. 356. 2007
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.. 356. 2007
Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia.. 355. 2006
AMG 531, a thrombopoiesis-stimulating protein, for chronic ITP.. 355. 2006
Chronic health conditions in adult survivors of childhood cancer.. 355. 2006
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.. 355. 2006
Will kinase inhibitors have a dark side?. 355. 2006
Dasatinib in imatinib-resistant Philadelphia chromosome-positive leukemias.. 354. 2006
Multidetector computed tomography for acute pulmonary embolism.. 354. 2006
The first months of the prescription-drug benefit--a CMS update.. 354. 2006
Altered bone and mineral metabolism in patients receiving imatinib mesylate.. 354. 2006
Intraperitoneal cisplatin and paclitaxel in ovarian cancer.. 354. 2006
A prescription for a modern Medicare program.. 353. 2005
Combined oral contraceptives in women with systemic lupus erythematosus.. 353. 2005
Antiretroviral therapy in a thousand patients with AIDS in Haiti.. 353. 2005
Messenger RNA for FOXP3 in the urine of renal-allograft recipients.. 353. 2005
Distinct sets of genetic alterations in melanoma.. 353. 2005
Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.. 353. 2005
Long-term outcomes of coronary-artery bypass grafting versus stent implantation.. 352. 2005
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.. 352. 2005
Topical microbicides become topical.. 352. 2005
Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.. 351. 2004
Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke.. 351. 2004
Effect of reducing interns' work hours on serious medical errors in intensive care units.. 351. 2004
Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.. 351. 2004
Circulating tumor cells, disease progression, and survival in metastatic breast cancer.. 351. 2004
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML.. 351. 2004
Primary care physicians who treat blacks and whites.. 351. 2004
Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection.. 350. 2004
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.. 349. 2003
A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer.. 349. 2003
Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia.. 349. 2003
Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy.. 349. 2003
Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus.. 348. 2003
A survey of liver transplantation from living adult donors in the United States.. 348. 2003
Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.. 348. 2003
State expenditures for tobacco-control programs and the tobacco settlement.. 347. 2002
Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.. 347. 2002
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.. 346. 2002
Participation in research and access to experimental treatments by HIV-infected patients.. 346. 2002
Variations in morbidity after radical prostatectomy.. 346. 2002
Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia.. 346. 2002
The influence of hospital volume on survival after resection for lung cancer.. 345. 2001
Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events.. 344. 2001
Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.. 344. 2001
Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.. 344. 2001
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.. 344. 2001
Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine.. 344. 2001
Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy.. 344. 2001
Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.. 344. 2001
Transplantation of embryonic dopamine neurons for severe Parkinson's disease.. 344. 2001
Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting.. 344. 2001
Cellular-telephone use and brain tumors.. 344. 2001
Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.. 343. 2000
A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.. 342. 2000
Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.. 342. 2000
Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage.. 342. 2000
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.. 341. 1999
Executives with white coats--the work and world view of managed-care medical directors. Second of two parts.. 341. 1999
Executives with white coats--the work and world view of managed-care medical directors. First of two parts.. 341. 1999
The unintended consequences of measuring quality on the quality of medical care.. 341. 1999
Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.. 341. 1999
Annexin II and bleeding in acute promyelocytic leukemia.. 340. 1999
Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.. 340. 1999
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.. 339. 1998
The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium.. 339. 1998
Outcomes among 562 recipients of placental-blood transplants from unrelated donors.. 339. 1998
Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide.. 339. 1998
Early pregnancy termination with mifepristone and misoprostol in the United States.. 338. 1998
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.. 338. 1998
Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy.. 337. 1997
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.. 337. 1997
Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.. 337. 1997
Fetal alloimmune thrombocytopenia.. 337. 1997
Diagnosis of pulmonary embolism with magnetic resonance angiography.. 336. 1997
Solid cancers after bone marrow transplantation.. 336. 1997
Variant-sequence transthyretin (isoleucine 122) in late-onset cardiac amyloidosis in black Americans.. 336. 1997
The DCC protein and prognosis in colorectal cancer.. 335. 1996
The association between birthplace and mortality from cardiovascular causes among black and white residents of New York City.. 335. 1996
Cardiac troponin T levels for risk stratification in acute myocardial ischemia. GUSTO IIA Investigators.. 335. 1996
Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup.. 334. 1996
The growth of medical groups paid through capitation in California.. 333. 1995
Thyroid hormone treatment after coronary-artery bypass surgery.. 333. 1995
Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy.. 333. 1995
Multidrug-resistant tuberculosis in patients without HIV infection.. 333. 1995
Fatal injuries after cocaine use as a leading cause of death among young adults in New York City.. 332. 1995
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas.. 332. 1995
Variability in radiologists' interpretations of mammograms.. 331. 1994
The use of levonorgestrel implants (Norplant) for contraception in adolescent mothers.. 331. 1994
Rearrangement of the bcl-6 gene as a prognostic marker in diffuse large-cell lymphoma.. 331. 1994
Cyclosporine in severe ulcerative colitis refractory to steroid therapy.. 330. 1994
Dose and dose intensity of adjuvant chemotherapy for stage II, node-positive breast carcinoma.. 330. 1994
Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop.. 330. 1994
Computed tomographic study of the common cold.. 330. 1994
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.. 329. 1993
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.. 329. 1993
Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup.. 328. 1993
Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis.. 327. 1992
Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred.. 327. 1992
The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group.. 327. 1992
Neurocysticercosis in an Orthodox Jewish community in New York City.. 327. 1992
Genetic linkage of the Marfan syndrome, ectopia lentis, and congenital contractural arachnodactyly to the fibrillin genes on chromosomes 15 and 5. The International Marfan Syndrome Collaborative Study.. 326. 1992
A controlled trial of fluconazole to prevent fungal infections in patients undergoing bone marrow transplantation.. 326. 1992
A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.. 326. 1992
Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis.. 326. 1992
Reasons that patients with acute myelogenous leukemia do not undergo allogeneic bone marrow transplantation.. 326. 1992
Sources of concern about the Patient Self-Determination Act.. 325. 1991
A randomized trial of intravesical doxorubicin and immunotherapy with bacille Calmette-Guérin for transitional-cell carcinoma of the bladder.. 325. 1991
Sex differences in the management of coronary artery disease. Survival and Ventricular Enlargement Investigators.. 325. 1991
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer.. 325. 1991
Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer.. 324. 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid).. 324. 1991
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.. 324. 1991
A randomized study of the effect of withdrawing hydroxychloroquine sulfate in systemic lupus erythematosus.. 324. 1991
Aldosterone synthesis in salt-wasting congenital adrenal hyperplasia with complete absence of adrenal 21-hydroxylase.. 324. 1991
A comparison between heparin and low-dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. Heparin-Aspirin Reperfusion Trial (HART) Investigators.. 323. 1990
Altered expression of the retinoblastoma gene product in human sarcomas.. 323. 1990
A randomized, controlled trial of interferon alfa-2b alone and after prednisone withdrawal for the treatment of chronic hepatitis B. The Hepatitis Interventional Therapy Group.. 323. 1990
Estimation of the risk of thrombocytopenia in the offspring of pregnant women with presumed immune thrombocytopenic purpura.. 323. 1990
Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation.. 323. 1990
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.. 322. 1990
A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study.. 322. 1990
Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors.. 322. 1990
Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.. 322. 1990
Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.. 321. 1989
Effect of triglyceride levels on methyl and methylene envelope line widths in proton nuclear magnetic resonance spectroscopy of human plasma.. 320. 1989
Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells.. 320. 1989
Treatment and prophylaxis of Isospora belli infection in patients with the acquired immunodeficiency syndrome.. 320. 1989
Association of the Lewis blood-group phenotype with recurrent urinary tract infections in women.. 320. 1989
Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy.. 320. 1989
Antenatal treatment of neonatal alloimmune thrombocytopenia.. 319. 1988
The association of patients' socioeconomic characteristics with the length of hospital stay and hospital charges within diagnosis-related groups.. 318. 1988
Inequities in health services among insured Americans. Do working-age adults have less access to medical care than the elderly?. 318. 1988
Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium.. 318. 1988
Infection with human T-cell leukemia virus type I in patients with leukemia.. 318. 1988
Allogeneic bone marrow transplantation after hyperfractionated total-body irradiation and cyclophosphamide in children with acute leukemia.. 317. 1987
Expression of opioid peptides in tumors.. 317. 1987
Exaggerated spontaneous release of platelet-derived growth factor by alveolar macrophages from patients with idiopathic pulmonary fibrosis.. 317. 1987
Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death.. 316. 1987
Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.. 316. 1987
The progesterone antagonist RU 486. A potential new contraceptive agent.. 316. 1987
Radioimmunodetection of cutaneous T-cell lymphoma with 111In-labeled T101 monoclonal antibody.. 315. 1986
Clinical manifestations and therapy of Isospora belli infection in patients with the acquired immunodeficiency syndrome.. 315. 1986
Local and systemic effects of intradermal recombinant interferon-gamma in patients with lepromatous leprosy.. 315. 1986
Termination of Medi-Cal benefits. A follow-up study one year later.. 314. 1986
The use of ambulatory testing in prepaid and fee-for-service group practices. Relation to perceived profitability.. 314. 1986
Neutrophil activation in thermal injury as assessed by increased expression of complement receptors.. 314. 1986
Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.. 313. 1985
The changing base line of complex ventricular arrhythmias. A new consideration in assessing long-term antiarrhythmic drug therapy.. 313. 1985
Reduced sensitivity of lymphocyte beta-adrenergic receptors in patients with endogenous depression and psychomotor agitation.. 313. 1985
Antibody to cardiolipin as a predictor of fetal distress or death in pregnant patients with systemic lupus erythematosus.. 313. 1985
Reduction in intraventricular hemorrhage by elimination of fluctuating cerebral blood-flow velocity in preterm infants with respiratory distress syndrome.. 312. 1985
Scientific misconduct in investigational drug trials.. 312. 1985
Lymphadenopathy-associated viral antibody in AIDS. Immune correlations and definition of a carrier state.. 311. 1984
Termination from Medi-Cal--does it affect health?. 311. 1984
Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.. 311. 1984
Pulmonary complications of the acquired immunodeficiency syndrome. Report of a National Heart, Lung, and Blood Institute workshop.. 310. 1984
The influence of hypermagnesemia on serum calcium and parathyroid hormone levels in human subjects.. 310. 1984
The pharmacokinetics of heroin in patients with chronic pain.. 310. 1984
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome.. 310. 1984
Summary of a workshop on the role of third-party payers in clinical trials of new agents.. 309. 1983
Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy.. 309. 1983
Characteristics of the acquired immunodeficiency syndrome (AIDS) in Haiti.. 309. 1983
Divalent cations in essential hypertension. Relations between serum ionized calcium, magnesium, and plasma renin activity.. 309. 1983
Pulmonary oxygen toxicity. Early reversible changes in human alveolar structures induced by hyperoxia.. 309. 1983
The effects of group size on test ordering for hypertensive patients.. 309. 1983
Absence of parathyroid hormone messenger RNA in nonparathyroid tumors associated with hypercalcemia.. 309. 1983
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia.. 309. 1983
Fluctuating cerebral blood-flow velocity in respiratory-distress syndrome. Relation to the development of intraventricular hemorrhage.. 309. 1983
Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.. 308. 1983
Preliminary observations on the effect of recombinant leukocyte A interferon in homosexual men with Kaposi's sarcoma.. 308. 1983
Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis.. 308. 1983
The prolactin response to thyrotropin-releasing hormone differentiates isolated gonadotropin deficiency from delayed puberty.. 308. 1983
Mode of inheritance of decreased C3b receptors on erythrocytes of patients with systemic lupus erythematosus.. 307. 1982
Participation of community hospitals in clinical trials: analysis of five years of experience in the Eastern Cooperative Oncology Group.. 306. 1982
Deficiency of platelet lipoxygenase activity in myeloproliferative disorders.. 306. 1982
An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction.. 305. 1981
Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.. 305. 1981
Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.. 305. 1981
Stopping medication in children with epilepsy: predictors of outcome.. 304. 1981
Clinical consequences of acquired transfusional iron overload in adults.. 304. 1981
Current concepts in immunology: the alternative pathway of complement--a system for host resistance to microbial infection.. 303. 1980
Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung.. 302. 1980
Relation of diet to high-density-lipoprotein cholesterol in middle-aged marathon runners, joggers, and inactive men.. 302. 1980
Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis.. 301. 1979
Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency.. 300. 1979
Renal transplantation between HLA identical siblings. Comparison with transplants from HLA semi-identical related donors.. 296. 1977
Pruritus in dialysis patients treated with parenteral lidocaine.. 296. 1977
Urinary temperature: a clue to early diagnosis of factitious fever.. 296. 1977
Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.. 295. 1976
Editorial: Glomerulonephritis, complement and C3NeF.. 294. 1976
Carrier detection in Duchenne muscular dystrophy.. 294. 1976
Acetylcholine receptor antibodies in myasthenia gravis.. 293. 1975
Predominantly T-cell infiltrate in rheumatoid synovial membranes.. 293. 1975
Detection and treatment of hypertension at the work site.. 293. 1975
Exacerbation of hereditary hepatic porphyria by surreptitious ingestion of an unusual provacative agent--a mouthwash preparation.. 292. 1975
Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.. 292. 1975
Letter: Acute hemolytic episodes 37 years apart.. 292. 1975
Adenocarcinoma in situ of Barrett's esophagus diagnosed by endoscopic cytology.. 291. 1974
The hemostatic defect produced by carbenicillin.. 291. 1974
Indomethacin-responsive hypercalcemia in a patient with renal-cell adenocarcinoma.. 291. 1974
Letter: Bilateral hilar adenopathy in amyloidosis.. 290. 1974
Isolated gonadotropin deficiency. A heterogenous syndrome.. 290. 1974
Paradox of the immune response to uncomplicated gonococcal urethritis.. 289. 1973
Initiation of globin synthesis in beta-thalassemia.. 288. 1973
Isolated deficiency of follicle-stimulating hormone. Clinical and laboratory features.. 287. 1972
Sustained bacteremia in patients with prosthetic cardiac valves.. 286. 1972
Physical fitness and metabolism.. 285. 1971
On the protein defect in abetalipoproteinemia.. 284. 1971
Macrophage migration inhibition test.. 283. 1970
Hyperbeta-lipoproteinemia in acute intermittent porphyria; preliminary report.. 282. 1970
Beta-apoprotein sufficiency and function.. 280. 1969
Infarction of the midgut associated with oral contraceptives. Report of two cases.. 279. 1968
Hodgkin's disease: value of bone-marrow biopsy.. 279. 1968
A time study of medical teaching rounds.. 273. 1965
THE POSTPERICARDIOTOMY SYNDROME: A SIX-YEAR EPIDEMIOLOGIC STUDY.. 272. 1965
Once-Weekly Semaglutide in Adults with Overweight or Obesity.. 385. 2021
Vaccine Breakthrough Infections with SARS-CoV-2 Variants.. 385. 2021
Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants.. 385. 2021
Effect of a Randomized, Controlled Trial on Surgery for Cervical Cancer.. 384. 2021
Oral Azacitidine Maintenance for Acute Myeloid Leukemia. Reply.. 384. 2021
Colchicine in Patients with Chronic Coronary Disease.. 384. 2021
Reconsidering the Trade-offs of Prostate Cancer Screening. Reply.. 383. 2020
Racial Differences in Genomic Profiling of Prostate Cancer.. 383. 2020
PCI or CABG for Left Main Coronary Artery Disease.. 383. 2020
Facing the Monster in Haiti.. 383. 2020
Hormone Therapy for Postmenopausal Women.. 382. 2020
Transforming ORs into ICUs.. 382. 2020
The Cost of Applying to Medical School.. 382. 2020
Active Surveillance for Black Men with Low-Risk Prostate Cancer in the United States.. 381. 2019
Immune Checkpoint Blockade plus Axitinib for Renal-Cell Carcinoma. Reply.. 380. 2019
Diagnosis of Suspected Pulmonary Embolism in Pregnancy.. 380. 2019
Treatment Approaches for Actinic Keratosis.. 380. 2019
Aspiration Pneumonia. Reply.. 380. 2019
Immune Escape of AML Cells after Transplantation.. 380. 2019
Allogeneic BK Virus-Specific T Cells for PML.. 380. 2019
Radial-Artery Grafts for Coronary-Artery Bypass Surgery.. 379. 2018
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer.. 379. 2018
Immune Checkpoint Blockade in Advanced Renal-Cell Carcinoma.. 379. 2018
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.. 378. 2018
Nivolumab and Ipilimumab in Advanced Melanoma.. 377. 2017
Primary Care Spending Rate - A Lever for Encouraging Investment in Primary Care.. 377. 2017
Bilateral versus Single Internal-Thoracic-Artery Grafts.. 376. 2017
Bilateral versus Single Internal-Thoracic-Artery Grafts.. 376. 2017
Acute Kidney Injury in Critically Ill Children and Young Adults.. 376. 2017
Niraparib in Recurrent Ovarian Cancer.. 376. 2017
Dietary Sodium and Cardiovascular Disease Risk.. 375. 2016
Biologic and Clinical Perspectives on Thyroid Cancer.. 375. 2016
Fresh versus Frozen Embryos in Polycystic Ovary Syndrome.. 375. 2016
Broadly Neutralizing Antibodies for HIV-1 Prevention or Immunotherapy.. 375. 2016
DNA-Repair Gene Mutations in Metastatic Prostate Cancer.. 375. 2016
More on Reevaluating PSA Testing Rates in the PLCO Trial.. 375. 2016
Urinary Tract Infections in Older Men.. 374. 2016
Reevaluating PSA Testing Rates in the PLCO Trial.. 374. 2016
Treatment of Advanced Renal-Cell Carcinoma.. 374. 2016
10-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti.. 374. 2016
Maintenance Intravenous Fluids in Acutely Ill Patients.. 374. 2016
Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma.. 373. 2015
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.. 373. 2015
Sterile pyuria.. 372. 2015
Rapid eradication of a bulky melanoma mass with one dose of immunotherapy.. 372. 2015
New agents for hyperkalemia.. 372. 2015
Infection with a chlorophyllic eukaryote after a traumatic freshwater injury.. 372. 2015
Genetic basis for clinical response to CTLA-4 blockade.. 372. 2015
Sodium and cardiovascular disease.. 371. 2014
More on robot-assisted laparoscopic radical cystectomy.. 371. 2014
Transcatheter aortic-valve replacement with a self-expanding prosthesis.. 371. 2014
A randomized trial of robot-assisted laparoscopic radical cystectomy.. 371. 2014
Protocol-based care for early septic shock.. 371. 2014
Sirolimus in severe hyperinsulinemic hypoglycemia.. 370. 2014
Ibrutinib resistance in chronic lymphocytic leukemia.. 370. 2014
Overall survival in renal-cell carcinoma with pazopanib versus sunitinib.. 370. 2014
Arthroscopic partial meniscectomy for degenerative meniscal tear.. 370. 2014
Early specialty palliative care.. 370. 2014
Pazopanib versus sunitinib in renal cancer.. 369. 2013
Urinary-cell mRNA and acute kidney-transplant rejection.. 369. 2013
Expanding the role of advanced nurse practitioners.. 369. 2013
Ischemic heart disease after breast cancer radiotherapy.. 368. 2013
Case 8-2013: A woman with carcinoma in situ of the breast.. 368. 2013
The OHRP and SUPPORT.. 368. 2013
Hepatotoxicity with combination of vemurafenib and ipilimumab.. 368. 2013
Radical prostatectomy versus observation for prostate cancer.. 367. 2012
Association of a HOXB13 variant with breast cancer.. 367. 2012
Finland, Weinstein, and the birth of antibiotic regret.. 367. 2012
Genetic profiling in acute myeloid leukemia.. 366. 2012
Grief, depression, and the DSM-5.. 366. 2012
Bortezomib to treat the TEMPI syndrome.. 366. 2012
Defining "patient-centered medicine".. 366. 2012
Vemurafenib sensitivity skin reaction after ipilimumab.. 366. 2012
Extracorporeal membrane oxygenation for ARDS in adults.. 366. 2012
Myeloma and second primary cancers.. 365. 2011
The Palliative Care Information Act.. 365. 2011
CABG in patients with left ventricular dysfunction.. 365. 2011
Myocardial viability in ischemic left ventricular dysfunction.. 365. 2011
One hundred years of Salvarsan.. 365. 2011
The Palliative Care Information Act in real life.. 364. 2011
Preexposure chemoprophylaxis for HIV prevention.. 364. 2011
Inhibition of mutated BRAF in melanoma.. 363. 2010
Robot-assisted surgery and health care costs.. 363. 2010
Suicide-related events in patients treated with antiepileptic drugs.. 363. 2010
Suicide-related events in patients treated with antiepileptic drugs.. 363. 2010
Is it always wrong to perform futile CPR?. 362. 2010
Fixing Medicare's physician payment system.. 362. 2010
Niacin compared with ezetimibe.. 362. 2010
Mutation in TET2 in myeloid cancers.. 361. 2009
5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti.. 361. 2009
Breast reconstruction after breast-cancer surgery.. 360. 2009
Military medical ethics.. 359. 2008
Acetaminophen poisoning.. 359. 2008
Multiple tumors in a child with germ-line mutations in TP53 and PTEN.. 359. 2008
Five genetic variants associated with prostate cancer.. 358. 2008
Corticosteroids for septic shock.. 358. 2008
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.. 358. 2008
Medical mystery: cloud surrounding the optic disks--the answer.. 358. 2008
Anabolic therapies for osteoporosis.. 357. 2007
Management of an inherited predisposition to breast cancer.. 357. 2007
Taenia solium neurocysticercosis.. 357. 2007
A comparison of three initial antiretroviral AIDS regimens.. 357. 2007
Sunitinib and hypothyroidism.. 356. 2007
Biomarkers for prediction of cardiovascular events.. 356. 2007
Uncovering an epidemic--screening for mental illness in teens.. 355. 2006
Violence and mental illness--how strong is the link?. 355. 2006
The script.. 355. 2006
Case 15-2006: the Budd-Chiari syndrome and V617F mutation in JAK2.. 355. 2006
Imatinib and altered bone and mineral metabolism.. 355. 2006
EGFR mutations in small-cell lung cancers in patients who have never smoked.. 355. 2006
Fondaparinux versus enoxaparin in acute coronary syndromes.. 354. 2006
Transforming growth factor beta signaling, vascular remodeling, and hypertension.. 354. 2006
One disease, two epidemics--AIDS at 25.. 354. 2006
Circumferential pulmonary-vein ablation for atrial fibrillation.. 354. 2006
The changing face of teenage drug abuse--the trend toward prescription drugs.. 354. 2006
Treatment of brain tumors.. 352. 2005
Clopidogrel versus aspirin and esomeprazole to prevent recurrent bleeding.. 352. 2005
Hepatic arterial infusion after liver resection.. 352. 2005
Interns' work hours.. 352. 2005
Deep-vein thrombosis.. 351. 2004
PSA velocity and prostate cancer.. 351. 2004
Priorities for the treatment of latent tuberculosis.. 351. 2004
Preventing complications of central venous catheterization.. 348. 2003
Elective primary cesarean delivery.. 348. 2003
Major birth defects after assisted reproduction.. 347. 2002
Sudden death due to cardiac arrhythmias.. 346. 2002
Learn nothing, forget nothing--the Medicare Commission redux.. 345. 2001
The cost effectiveness of antiretroviral therapy for HIV disease.. 345. 2001
Dietary sodium and blood pressure.. 344. 2001
The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis.. 343. 2000
Effect of ramipril on cardiovascular events in high-risk patients.. 343. 2000
Gestational diabetes.. 342. 2000
Genetic and phenotypic correlates of colorectal cancer in young patients.. 342. 2000
Chronic myeloid leukemia.. 341. 1999
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.. 341. 1999
Legalized physician-assisted suicide in Oregon.. 341. 1999
Epstein-Barr virus-associated lymphoma after treatment of macroglobulinemia with cladribine.. 341. 1999
Long-acting gonadotropin-releasing hormone implant to maintain medical castration for two years in men with prostate cancer.. 340. 1999
Problems evaluating contamination of dietary supplements.. 340. 1999
Ethical complexities of conducting research in developing countries.. 337. 1997
The DCC protein and colon cancer.. 336. 1997
Interleukin-2 infusions in HIV-infected patients.. 336. 1997
ICD-9 code for palliative or terminal care.. 335. 1996
Allelic loss of chromosome 1p in neuroblastoma.. 334. 1996
Breast cancer and BRCA1 mutations.. 334. 1996
Community-acquired pneumonia.. 334. 1996
Body-cavity-based lymphoma in an HIV-seronegative patient without Kaposi's sarcoma-associated herpesvirus-like DNA sequences.. 334. 1996
Clarithromycin-related toxic effects of digoxin.. 333. 1995
Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient.. 333. 1995
Abuse and neglect of elderly persons.. 333. 1995
Economic implications of assisted reproductive technology.. 331. 1994
The advantage of rearranging bcl-6.. 331. 1994
Breast implants and connective-tissue diseases.. 331. 1994
Treatment of the serotonin syndrome with cyproheptadine.. 331. 1994
Withdrawal of conclusion: false positive tests for HIV in a woman with lupus.. 331. 1994
Chemotherapy for colorectal cancer.. 331. 1994
Donor T cells to treat EBV-associated lymphoma.. 331. 1994
Gastrointestinal bleeding in critically ill patients.. 331. 1994
Conservative management of prostate cancer.. 330. 1994
Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis.. 330. 1994
Plasma renin activity and ischemic heart disease.. 330. 1994
Mucosa-associated lymphoid-tissue lymphoma.. 329. 1993
Prevention and treatment of traveler's diarrhea.. 329. 1993
Pathogenetic mechanisms of septic shock.. 329. 1993
Defective visual pathway in reading-disabled children.. 329. 1993
CD4+ T-lymphocytopenia without HIV infection.. 328. 1993
CD4+ T-lymphocytopenia without HIV infection.. 328. 1993
Antibodies to L-type calcium channels in amyotrophic lateral sclerosis.. 328. 1993
Tacrine in Alzheimer's disease.. 328. 1993
Telling the diagnosis of Alzheimer's disease.. 328. 1993
Fatal hospital-acquired multidrug-resistant tuberculous pericarditis in two patients with AIDS.. 327. 1992
Hypertension and catecholamine biosynthesis associated with a glomus jugulare tumor.. 327. 1992
Aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.. 327. 1992
Use of phentolamine for cocaine-induced myocardial ischemia.. 327. 1992
More on SI units.. 327. 1992
Synthetic surfactants in infants with respiratory distress syndrome.. 326. 1992
Antiphospholipid antibodies and fetal loss.. 326. 1992
Response of refractory thrombotic thrombocytopenic purpura to extracorporeal immunoadsorption.. 326. 1992
Hydroxychloroquine in systemic lupus erythematosus.. 325. 1991
Pneumocystis carinii pneumonia developing within one month of intensive chemotherapy for treatment of acute lymphoblastic leukemia.. 325. 1991
Etidronate for postmenopausal osteoporosis.. 323. 1990
Calcium-antagonist receptors in cardiomyopathy.. 321. 1989
Lack of effect of pregnancy or hematin therapy on erythrocyte porphobilinogen deaminase activity in acute intermittent porphyria.. 321. 1989
Stuttering.. 320. 1989
Vascular response in diabetes with neuropathic foot lesions.. 319. 1988
Congenital adrenal hyperplasia and fertility.. 319. 1988
Case 11-1988.. 319. 1988
Circulating interferon gamma in AIDS patients treated with interleukin-2.. 318. 1988
Selective hypoaldosteronism and impairment of angiotensin II production.. 317. 1987
Aminoglycoside effects on voltage-sensitive calcium channels and neurotoxicity.. 317. 1987
High-molecular-weight serum thyrotropin revisited.. 316. 1987
More on metoclopramide and tardive dyskinesia.. 316. 1987
Tardive dyskinesia associated with high-dose intravenous metoclopramide.. 315. 1986
Metastatic neuroblastoma after 52 years of apparent dormancy.. 315. 1986
Toxic keratopathy associated with suramin therapy.. 314. 1986
Methyldopa and reticuloendothelial function.. 314. 1986
Follow-up at 41/2 years on homosexual men with generalized lymphadenopathy.. 313. 1985
AIDS in a bodybuilder using anabolic steroids.. 311. 1984
Familial nature of Alzheimer's disease?. 311. 1984
Needle-stick injuries during the care of patients with AIDS.. 310. 1984
Diet and sleep patterns in newborn infants.. 310. 1984
Major surgery and scleromyxedema.. 310. 1984
Extrapyramidal reactions with high-dose metoclopramide.. 309. 1983
Acquired immunodeficiency in Haitians.. 308. 1983
Effects of naloxone in senile dementia: a double-blind trial.. 308. 1983
Nuclear magnetic resonance.. 305. 1981
Catecholamines, dopamine, and endorphin levels during extreme exercise.. 305. 1981
Serial thoracenteses in parapneumonic effusions.. 304. 1981
The skin and T-cell differentiation.. 303. 1980
Artificial intelligence.. 302. 1980
Bleomycin for treatment of immune cytopenia.. 302. 1980
Marrow transplantation for acute nonlymphoblastic leukemia.. 302. 1980
Treatment of vasculitis with cyclophosphamide.. 301. 1979
Uveitis and the immunologically compromised host.. 299. 1978
Transient autoimmune hemolytic anemia and pulmonary tuberculosis.. 299. 1978
Unusual pleocytosis in aseptic meningitis.. 297. 1977
Prenatal diagnosis of acute intermittent porphyria.. 295. 1976
Uncoupling Metastasis from Tumorigenesis. 2023
Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years. 2017
Duration of clopidogrel therapy with drug-eluting stents. 2010
Zolbetuximab in Gastric or Gastroesophageal Junction Adenocarcinoma. 2024
Recombinant ADAMTS13 for Immune Thrombotic Thrombocytopenic Purpura. 2024
Drug-Eluting Resorbable Scaffold for Infrapopliteal Artery Disease. Reply. 2024
Genetic Basis of Relapse after GPRC5D-Targeted CAR T Cells. 2023
Extent of Surgery for Stage IA Non-Small-Cell Lung Cancer. Reply. 2023
Safety of Health Care in the Inpatient Setting. 2023
Dapagliflozin in Heart Failure with Preserved Ejection Fraction. 2023
Protection against Reinfection with the Omicron BA.2.75 Subvariant. 2023
GPRC5D-Targeted CAR T Cells for Myeloma. Reply. 2022
Resurgence of Cholera in Haiti amidst Humanitarian Crises. 2022
Vitamin D and Incident Fractures. 2022
Tirzepatide Once Weekly for the Treatment of Obesity. Reply. 2022
Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2. 2022
Protective Effect of Previous SARS-CoV-2 Infection against Omicron BA.4 and BA.5 Subvariants. 2022
Nonoperative Management of Childhood Calvarial Langerhans-Cell Histiocytosis. 2022
Evaluation of Acute Adverse Events after Covid-19 Vaccination during Pregnancy. 2022
Protection against the Omicron Variant from Previous SARS-CoV-2 Infection. 2022
Waning mRNA-1273 Vaccine Effectiveness against SARS-CoV-2 Infection in Qatar. 2022
Effectiveness of mRNA-1273 and BNT162b2 Vaccines in Qatar. 2022
Efficacy of Natural Immunity against SARS-CoV-2 Reinfection with the Beta Variant. 2021
Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons. 2021
Efpeglenatide and Heart and Kidney Outcomes in Type 2 Diabetes. 2021
MRI-Targeted Biopsy in Prostate Cancer Screening. 2021
Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections. 2021
Antibiotics versus Appendectomy for Acute Appendicitis - Longer-Term Outcomes. 2021
Stress Incontinence in Women. 2021
Diabetes Treatment and Control in U.S. Adults. 2021
Antithrombotic Therapy after Acute Coronary Syndromes. Reply. 2021
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer. 2020
Uterine-Artery Embolization or Myomectomy for Uterine Fibroids. 2020
Triple Inhaled Therapy in COPD. Reply. 2020
Elagolix for Fibroid-Associated Heavy Menstrual Bleeding. 2020
Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young. 2020
Covid-19 and Kidney Transplantation. 2020
Clinical Characteristics of Covid-19 in New York City. 2020
Palbociclib and Fulvestrant in Breast Cancer. Reply. 2019
Azithromycin and Childhood Mortality in Africa. 2018
Enzalutamide in Castration-Resistant Prostate Cancer. 2018
Diagnosis and Management of the Antiphospholipid Syndrome. 2018
Idiopathic Pulmonary Fibrosis. 2018
Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes. 2018
Change in Overweight from Childhood to Early Adulthood and Risk of Type 2 Diabetes. 2018
Canakinumab for Atherosclerotic Disease. 2018
Bariatric Surgery or Intensive Medical Therapy for Diabetes after 5 Years. 2017
Left Ventricular Assist Devices for Advanced Heart Failure. 2017
Trial of Transplantation of HCV-Infected Kidneys into Uninfected Recipients. 2017
Betrixaban in Acutely Ill Medical Patients. 2016
Colorectal Cancer on the Decline. 2016
Radiation plus Chemotherapy in Low-Grade Glioma. 2016
Glioproliferative Lesion of the Spinal Cord as a Complication of "Stem-Cell Tourism". 2016
Lenalidomide plus Rituximab for Mantle-Cell Lymphoma. 2016
Cryopreservation of Oocytes. Author replies. 2016
Takotsubo (Stress) Cardiomyopathy. 2015
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer. 2015
Everolimus-Eluting Stents or Bypass Surgery for Coronary Disease. 2015
Donor activating KIR2DS1 in leukemia. 2014
Case 18-2014: A man with a rash, myalgia, and weakness. 2014
Cryptogenic stroke and atrial fibrillation. 2014
Antidepressant use in pregnancy and the risk of cardiac defects. 2014
Bariatric surgery versus intensive medical therapy for diabetes. 2014
Albumin-bound paclitaxel plus gemcitabine in pancreatic cancer. 2014
Acquired resistance to crizotinib from a mutation in CD74-ROS1. 2013
Platelet inhibition with cangrelor during PCI. 2013
ERBB2 inhibition and heart failure. 2013
Peripheral-blood versus bone marrow stem cells. 2013
Enzalutamide in prostate cancer after chemotherapy. 2012
Lecture halls without lectures. 2012
Abscopal effect in a patient with melanoma. 2012
Reduced lung-cancer mortality with CT screening. 2011
Body-mass index and risk of death in Asians. 2011
Specialist practices as medical homes. 2010
Stem-cell transplantation for sickle cell disease. 2010
More on atypical fractures of the femoral diaphysis. 2008
More on melanoma with transdifferentiation. 2008
Melanoma complicating treatment with natalizumab for multiple sclerosis. 2008
HER2 and response to paclitaxel in node-positive breast cancer. 2008
A gene signature in breast cancer. 2007
CT screening for lung cancer. 2007
Virtual colonoscopy to screen for colorectal cancer. 2004
Virtual colonoscopy to screen for colorectal cancer. 2004
More on pseudohypocalcemia and gadolinium-enhanced MRI. 2004
Surgical treatment of esophageal cancer. 2003
Thrombolytic therapy in patients with submassive pulmonary embolism. 2003
Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. 2001
Executives with white coats--managed-care medical directors. 2000
The relation between somatic symptoms and depression. 2000
The unintended consequences of measuring quality on the quality of medical care. 2000
Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia. 1999
Low-fat diets. 1998
Antiphospholipid antibodies, annexin V, and pregnancy loss. 1997
Perioperative normothermia and surgical-wound infection. 1996
Diltiazem and subacute cutaneous lupus erythematosus-like lesions. 1995
Staging of head and neck cancer. 1995
Breast implants and connective-tissue diseases. 1994
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. 1993
Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. 1993
Skin cancer and HLA antigens. 1992
Anaphylaxis from a tick bite. 1991
Losec or Lasix? 1990
Tropical spastic paraparesis: HTLV-I antibodies in patients from the Seychelles. 1987
Anticardiolipin antibodies in pregnant patients with systemic lupus erythematosus. 1986
Long-term follow-up of patients with mitral-valve prolapse. 1986
Altered calcium uptake in cultured skin fibroblasts from patients with Alzheimer's disease. 1985
CSF rhinorrhea after bromocriptine for prolactinoma. 1982
Chinese food and platelets. 1980
Hypertrophic cardiomyopathy. 1979
HLA and ABO blood groups in blacks with mitral-valve prolapse. 1978
Dialysance of iodide. 1978
Case 17-2024: A 45-Year-Old Woman with Metastatic Breast Cancer. 2024
Case 14-2021: A 64-Year-Old Woman with Fever and Pancytopenia. 2021
Case 9-2019: A 62-Year-Old Man with Atrial Fibrillation, Depression, and Worsening Anxiety. 2019
Phosphatidylinositol 3-Kinase, Growth Disorders, and Cancer. 2018
Case 12-2017 - A 34-Year-Old Man with Nephropathy. 2017
Case records of the Massachusetts General Hospital. Case 28-2005. A 42-year-old man with weight loss, weakness, and a rash. 2005
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 2-2002- a 58-year-old woman with unilateral loss of vision and postmenopausal bleeding. 2002
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 38-2001. A 51-year-old woman with lung cancer and neuropsychiatric abnormalities. 2001
Tenecteplase for Stroke - Opening the Window? 2024
Chronic Kidney Disease - Another Step Forward.. 388. 2023
More COACHing Needed to Optimize Care after Heart Failure Hospitalization.. 388. 2023
Parenteral Protein in Extremely Preterm Infants - More Is Not Better.. 387. 2022
Targeting Oncogenic RAS Protein.. 387. 2022
The Price of Freedom from Tricuspid Regurgitation. 2021
Finally, Effective Inhibitors of Mutant KRAS.. 384. 2021
mRNA Covid-19 Vaccines in Pregnant Women.. 384. 2021
A Successful Trial for Lupus - How Good Is Good Enough?. 382. 2019
TAILORing Adjuvant Systemic Therapy for Breast Cancer.. 379. 2018
Cytoreductive Nephrectomy - Patient Selection Is Key.. 379. 2018
Targeting Inflammation in Coronary Artery Disease.. 377. 2017
Air Pollution Still Kills.. 376. 2017
Roads Diverge--A Robert Frost View of Leukemia Development.. 374. 2016
Reexcision--The Other Breast Cancer Epidemic.. 373. 2015
Nodal Irradiation after Breast-Cancer Surgery in the Era of Effective Adjuvant Therapy.. 373. 2015
Selecting revascularization strategies in patients with coronary disease.. 372. 2015
Accountable care organizations--the risk of failure and the risks of success.. 371. 2014
Heart-rhythm monitoring for evaluation of cryptogenic stroke.. 370. 2014
Bevacizumab in glioblastoma--still much to learn.. 370. 2014
Another piece of the myeloproliferative neoplasms puzzle.. 369. 2013
Transplantation for alcoholic hepatitis--time to rethink the 6-month "rule".. 365. 2011
Eliminating cells gone astray.. 365. 2011
Even better kinase inhibitors for chronic myeloid leukemia.. 362. 2010
Ten years on--the human genome and medicine.. 362. 2010
A common genetic mechanism in malignant bone marrow diseases.. 360. 2009
Arthroscopic surgery for osteoarthritis of the knee?. 359. 2008
Neuroblastoma--linking a common allele to a rare disease.. 358. 2008
Cost sharing for health care--whose skin? Which game?. 358. 2008
Collaboration, genetic associations, and lupus erythematosus.. 358. 2008
Breast-cancer therapy--looking back to the future.. 357. 2007
Cyclophosphamide for scleroderma lung disease.. 354. 2006
Reducing the risk of gynecologic cancer in the Lynch syndrome.. 354. 2006
Chemotherapy for brain tumors--a new beginning.. 352. 2005
The Economics of ICDs.. 351. 2004
Elective single-embryo transfer--has its time arrived?. 351. 2004
Breast cancer screening with MRI--what are the data for patients at high risk?. 351. 2004
Defining adequate surgery for primary melanoma.. 350. 2004
Treatment of the antiphospholipid syndrome.. 349. 2003
The prevention of prostate cancer--the dilemma continues.. 349. 2003
"Silent" strokes and dementia.. 348. 2003
Warfarin for venous thromboembolism - walking the dosing tightrope.. 348. 2003
Kala-azar--progress against a neglected disease.. 347. 2002
Getting ready for gene-based medicine.. 347. 2002
Rational local therapy for breast cancer.. 347. 2002
New treatments for psoriasis.. 345. 2001
Disparities in the use of total joint arthroplasty.. 342. 2000
Genetic prognostic markers for colorectal cancer.. 342. 2000
Markers of asphyxia and neonatal brain injury.. 341. 1999
Evaluating the burden of disease and spending the research dollars of the National Institutes of Health.. 340. 1999
Aortic disease in Marfan's syndrome.. 340. 1999
"Annexinopathies"--a new class of diseases.. 340. 1999
Elective cesarean delivery to reduce the transmission of HIV.. 340. 1999
Lymph-node dissection for gastric cancer.. 340. 1999
Medical education and managed care.. 340. 1999
Venous thrombosis as a chronic disease.. 340. 1999
Appetite suppressants and valvular heart disease.. 339. 1998
Improving outpatient psychiatric care.. 336. 1997
Low-molecular-weight heparin--an opportunity for home treatment of venous thrombosis.. 334. 1996
P-glycoprotein--a marker of cancer-cell behavior.. 333. 1995
Rethinking utilization review.. 333. 1995
The pneumococcus at the gates.. 333. 1995
Answers to the antiphospholipid-antibody syndrome?. 332. 1995
Factor V Leiden--an unselfish gene?. 331. 1994
New approaches to the treatment of bladder cancer.. 329. 1993
Cancer and clotting--Trousseau's warning.. 327. 1992
Metastatic breast cancer. Length and quality of life.. 325. 1991
Immunosuppression in aplastic anemia--postponing the inevitable?. 324. 1991
Cholesterol intake and serum cholesterol level.. 324. 1991
Therapy for systemic lupus erythematosus.. 324. 1991
Diagnosis and prognosis of mitral-valve prolapse.. 320. 1989
Hospital prospective payment and the quality of care.. 319. 1988
New promise for autologous marrow transplants in leukemia.. 315. 1986
Apolipoprotein C-II deficiency revisited.. 310. 1984
apo-C-II deficiency: a new mutant.. 298. 1978
Autonomy and ethics in action.. 297. 1977
Von Willebrand's disease and the molecular pathology of hemostasis.. 296. 1977
Aspiration Pneumonia. 2019
Update on Keratinocyte Carcinomas. 2018
Diagnosis and Management of the Antiphospholipid Syndrome. 2018
Systemic Therapy for Metastatic Renal-Cell Carcinoma. 2017
Biologic and Clinical Perspectives on Thyroid Cancer. 2016
Elder Abuse. 2015
Sterile pyuria. 2015
Mold infections of the central nervous system. 2014
General anesthesia, sleep, and coma. 2010
Platelets, petechiae, and preservation of the vascular wall. 2008
Local therapy and survival in breast cancer. 2007
Cancer stem cells. 2006
Clinical practice. Surveillance strategies after curative treatment of colorectal cancer. 2004
Thrombocytosis. 2004
How contagious is vaccinia? 2002
Medical termination of pregnancy. 2000
Chronic myeloid leukemia. 1999
Testicular germ-cell cancer. 1997
Renal-cell carcinoma. 1996
Abuse and neglect of elderly persons. 1995
Renal transplantation. 1994
Progress in psychiatry (2). 1993
Progress in psychiatry (1) 1993
Mifepristone (RU 486)--a modulator of progestin and glucocorticoid action. 1993
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract. 1984
Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (first of two parts). 1984
Total parenteral nutrition in the cancer patient. 1981
Phospholipids in biology and medicine (second of two parts). 1974
Intravenous feeding. 1972
Management of Antithrombotic Therapy after Acute Coronary Syndromes. 2021
Severe Covid-19. 2020
Chimeric Antigen Receptor Therapy. 2018
Idiopathic Pulmonary Fibrosis. 2018
CLINICAL PRACTICE. Primary Care for Men Who Have Sex with Men. 2015
Pancreatic cancer. 2010
Clinical practice. Primary retinal detachment. 2008
Monoclonal antibody therapy for B-cell non-Hodgkin's lymphoma. 2008
Clinical practice. Patent foramen ovale in young adults with unexplained stroke. 2005
Diseases of the retina. 1994
The heart in hypertension. 1992

VIVO Weill Cornell Medical College

The New England journal of medicine Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)